Point72 Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Point72 Asset Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,389,403	Closed	-$3.42M	–	4277
2026 Q1	$3.42M	Sell	1,389,403 -909,098	-40%	-$3.04M	﹤0.01%	1951
2025 Q4	$9.15M	Buy	2,298,501 +2,221,153	+2,872%	+$9.83M	0.01%	1417
2025 Q3	$292K	Buy	+77,348	New	+$263K	﹤0.01%	2075
2022 Q1	–	Sell	-16,900	Closed	-$801K	–	1271
2021 Q4	$801K	Buy	+16,900	New	+$1.01M	﹤0.01%	938

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management's NBP Position: Q2 2026 in Review

Point72 Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026, closing a stake of 1,389,403 shares — an estimated $3.42M sold.

Point72 Asset Management first reported a position in NBP in Q4 2021 and held it in 4 quarters. The position peaked at $9.15M in Q4 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Point72 Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2026 after selling out during the quarter.
Point72 Asset Management sold 1,389,403 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $3.42M.
Point72 Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2021 and held it in 4 quarters.
Point72 Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $9.15M in Q4 2025.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.